Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-22

Clinical Trial Update: Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dutasteride for spinal and bulbar muscular atrophy (Kennedy's disease) has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DUTASTERIDE (Dutasteride)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Kennedy's Disease, Spinal and Bulbar Muscular Atrophy | Phase 2 | Status: COMPLETED | Results posted: 2010-06-22